Aamir Butt, chief executive of , spoke to Andrew Scott ahead of the company's first live broadcast with Proactive Investors.
Lancor is aiming to carry out an initial coin offering by issuing Medici, a new currency based on Ethereum, to help Tumour Trace to fund its further development.
To learn more about Lancor and Medici click here
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Lancor Scientific named herein, including the promotion by the Company of Lancor Scientific in any Content on the Site, the Company receives...
FOR OUR FULL DISCLAIMER CLICK HERE